Cambridge Orthopaedic Labs: Shareholder Update Q4, 2021

The COL team has been focused on the preparations for the FDA submission and the pre- and post-launch critical steps that will lay the groundwork for our US launch in 2022
The critical steps leading to the launch continue to be put into place and our priorities have remained: Manufacturing, Regulatory, Sales Preparation and Financing.